Adult-use retail sales begin July 1, 2027 under the compromise legislation signed into law as part of the Virginia state budget on June 29, 2026. The Cannabis Control Authority will begin accepting retail and microbusiness license applications on February 1, 2027. Governor Abigail Spanberger initially vetoed the standalone adult-use bill on May 19, 2026, but reached a compromise with legislative sponsors Sen. Lashrecse Aird and Del. Paul Krizek on June 16, 2026 that was enacted into the budget. Up to 350 retail establishment licenses and up to 100 microbusiness licenses are authorized.

Existing medical pharmaceutical processors must pay a $10 million entry fee to participate in the adult-use market. This is a compromise between the House proposal of $5 million and the Senate proposal of $15 million. The fee is in addition to ongoing operational costs of expanding into adult-use retail. For most operators, this is a serious capital decision that requires modeling against expected adult-use revenue, the dual federal tax regime (medical operations remain Schedule III, adult-use operations remain Schedule I), and the operational complexity of running both license types simultaneously.

The state cannabis tax is 6% at launch on July 1, 2027, rising to 8% on July 1, 2029. Localities may impose an additional 1 to 3.5% local cannabis tax. Combined with Virginia's existing sales and use tax, the effective consumer tax rate typically falls between 12 and 16%. Microbusinesses may operate up to two locations under their license. Note that adult-use operations remain Schedule I at the federal level (subject to 280E), unlike Virginia medical operations which became Schedule III in April 2026.

On April 22, 2026, the U.S. Department of Justice and DEA issued a final order placing state-licensed medical marijuana into Schedule III of the Controlled Substances Act effective immediately. For qualifying medical cannabis operators, Section 280E no longer applies to medical activities going forward. Virginia medical pharmaceutical processors may now deduct ordinary business expenses on their federal medical return. Combined with Virginia's 2023 state 280E decoupling, Virginia medical operators now have full ordinary-business-expense deductibility on both federal and state returns for medical operations. Treasury has not yet issued retroactive guidance, and the order faces ongoing D.C. Circuit litigation, so amended return decisions for prior years require careful evaluation. Adult-use operations remain Schedule I.

Virginia cannabis operators need a cannabis-specific chart of accounts structured for inventory capitalization, integrated point-of-sale and seed-to-sale tracking, COGS allocation workflows that handle the dual federal regime (Schedule III medical and Schedule I adult-use), payroll systems with proper labor allocation across operations, and financial reporting capable of satisfying CCA compliance, IRS audit defense, and investor reporting standards. Operators holding both medical and adult-use licenses will run two parallel federal tax frameworks within one business, which generic accounting systems are not built to handle.

Yes, the Virginia license framework does not prohibit out-of-state ownership of retail establishment or microbusiness licenses. The Cannabis Impact Business Support Team and equity provisions in the framework prioritize Virginia-based and impact-community applicants, and license fee deposits are weighted toward equity applicants, but the market is structured to accept multi-state operator participation. For MSOs already operating in California, New York, Michigan, Florida, or other markets, Virginia adds a new state to the multi-state tax reconciliation and consolidated reporting framework, including any necessary intercompany structuring across the Schedule III medical and Schedule I adult-use regimes.